GeneTex
United States (US)

Enrofloxacin/Ciprofloxacin antibody [1.BB.892]

Cat No. GTX15060

Host Mouse
Clonality Monoclonal
Clone Name 1.BB.892
Isotype IgM
Application ELISA
APPLICATION

Application Note

ELISA: Use at an assay dependent dilution. Optimal dilutions/concentrations should be determined by the end user.

Specificity/Sensitivity

GTX15060 reacts equally well with enrofloxacin and its main metabolite, ciprofloxacin.
PROPERTIES

Form

Liquid

Buffer

Preservative: NoneConstituents: PBS. pH 7.4

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

1 mg/ml (Please refer to the vial label for the specific concentration.)

Immunogen

Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide.

Purification

Purified IgM

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Background

Ciprofloxacin, a fluoroquinolone, is a concentration dependent bactericidal agent. It is structurally related to enrofloxacin, and has a similar spectrum of activity. Both of these antimicrobials have shown activity against some gram positive aerobes and a wide range of gram negative bacilli and cocci, which include Klebsiella, Pseudomonas, Salmonella, and other organisms such as Mycoplasma, Staphylococci and Chlamydia. Due to the fluoroquinolones variable activity against most Streptococci, as well as their weak activity against many anaerobic bacteria, they are generally not recommended for use in treating infections where these types of microbes are present. Like enrofloxacin, ciprofloxacin is believed to act by inhibiting bacterial DNA gyrase which prevents DNA supercoiling and DNA synthesis.
Package List Price ($)
$ 319